Studies have shown that pharmacological upregulation of the eNOS-NO-cGMP-PKG pathway can effectively improve myocardial hypertrophy and interstitial fibrosis and improve myocardial function.37,43 Therefore. The gene discussed is PRKG1; the disease is cardiac hypertrophy.